
No results matched your search
Quotient Technology (NYSE:QUOT): Q4 GAAP EPS of -$0.28 misses by $0.19.Revenue of $142.5M (+20.2% Y/Y) beats by $21.48M.Press Release
Quotient (NASDAQ:QTNT) FQ3 results:Revenues: $8.75M (+10.2%).Net Loss: ($29.76M) (+8%); Loss Per Share: ($0.29); As of December 31, 2020, cash and cash equivalents of $143.5MFY...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Filter Table By:
Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
---|---|---|---|---|---|
Completed Patterns | |||||
Bullish doji Star | 15 | 1 | Mar 05, 2021 21:30 | ||
Falling Three Methods | 1D | 2 | Mar 03, 2021 | ||
Abandoned Baby Bullish | 30 | 2 | Mar 05, 2021 20:30 | ||
Bullish Engulfing | 30 | 2 | Mar 05, 2021 20:30 | ||
Bullish doji Star | 1H | 3 | Mar 05, 2021 18:00 |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
Zenith Bank | 25.40 | 25.40 | 25.20 | +0.05 | +0.20% | 4.71M | 10:49:00 | ||
Guaranty Trust Bank | 31.00 | 31.00 | 31.00 | 0.00 | 0.00% | 207.82K | 10:49:00 | ||
UBA | 8.00 | 8.05 | 8.05 | +0.10 | +1.26% | 382.57K | 10:46:00 | ||
FBN Holdings | 6.95 | 6.95 | 6.95 | -0.15 | -2.11% | 56.33K | 10:48:00 | ||
MTN Nigeria | 160.50 | 160.50 | 160.50 | -9.50 | -5.59% | 243.96K | 10:46:00 | ||
United Capital | 4.700 | 4.700 | 4.610 | -0.320 | -6.37% | 3.37M | 10:48:00 | ||
Access Bank | 7.85 | 7.85 | 7.85 | +0.05 | +0.64% | 93.28K | 10:47:00 | ||
Jaiz Bank | 0.68 | 0.68 | 0.68 | +0.01 | +1.49% | 10.44K | 10:40:00 | ||
Conoil | 18.90 | 18.90 | 18.90 | 0.00 | 0.00% | 11.97K | 10:30:00 | ||
Fidson | 4.640 | 4.640 | 4.640 | -0.010 | -0.22% | 6.17K | 10:35:00 |
Quotient Limited is a diagnostics company. The Company focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. It is engaged in developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market. It is engaged in developing MosaiQ, which is its technology platform. The Company develops, manufactures and commercializes the products, including antisera products, reagent red blood cells, whole blood controls and ancillary products. Its antisera products contain antibodies used to identify blood group antigens. Its antisera products are monoclonal antibodies manufactured from master cell lines it owns. Its reagent red blood cells products are composed of human red blood cells formulated to enable the identification of blood group antibodies. The Company develops, manufactures and sells conventional reagent products to original equipment manufacturers (OEMs).
Read MoreAre you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review